Sanofi
Sanofi (SNY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SNY · as of Jun 8, 2026
Key Statistics
Explore Sanofi Data
sny stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 27 · Buy rate: 51.9%
The SNY analyst consensus is Buy, based on ratings from 27 Wall Street analysts over the past 3 months. The average 12-month price target is $51.00, representing +13.28% upside from the current price of $45.02.
Competitors & Peers
sny competitorsSNY
AMGN
BMY
CELG-RI
CVS
GILDStock Performance
Full HistoryAbout Sanofi
Sanofi together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through…
what is sanofi · sny stock overview · sanofi company profile · who is sanofi ceo · sny NASDAQ · sanofi headquarters · sanofi business segments
About Stock Overview & Key Data
Sanofi (SNY) is a Healthcare company in the Drug Manufacturers - General industry, listed on NASDAQ since Jul 1, 2002. As of the latest trading session, SNY stock price is $45.02, with a market capitalization of $108.4B. The stock has returned -9.51% over the past 12 months and -7.10% year-to-date.
According to 27 Wall Street analysts, the consensus rating for Sanofi stock is Buy, with an average 12-month price target of $51.00. In fiscal year 2025, Sanofi reported revenue of $46.7B and net income of $7.8B. For detailed data — including Sanofi revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Sanofi (SNY) stock price is $45.02. The stock is traded on NASDAQ under the ticker symbol SNY. The 52-week range is $42.28 – $52.68.